Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Halpern

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Diabetologia|June 18, 2016
Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapyBruno Halpern, Cintia Cercato, Marcio C Mancini
Diabetes Care|May 24, 2017
Comment on Cummings and Cohen. Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m<sup>2</sup>. Diabetes Care 2016;39:924-933Bruno Halpern, Cintia Cercato, Marcio Correa Mancini
The Journal of Clinical Endocrinology and Metabolism|May 31, 2018
Case Report of Acquired Generalized Lipodystrophy Associated With Common Variable ImmunodeficiencyBruno Halpern, Marcia Nery, Maria Adelaide Albergaria Pereira
Diabetology & Metabolic Syndrome|March 5, 2022
Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerationsThiago Bosco Mendes, Alexandre Barbosa Câmara-de-Souza, Bruno Halpern
Obesity Research & Clinical Practice|June 18, 2020
Extrinsic compression of pancreatic duct by intragastric balloon treatment and its potential to cause acute pancreatitis: Two case reports and clinical discussionBruno Halpern, Mauricio Paulin Sorbello, Hilton Telles Libanori, et al.
Obesity Research & Clinical Practice|March 5, 2020
Extrinsic compression of pancreactic duct by intragastric balloon treatment and its potential to cause acute pancreatitis: two case reports and clinical discussionBruno Halpern, Mauricio Paulin Sorbello, Hilton Telles Libanori, et al.
Diabetology & Metabolic Syndrome|April 8, 2025
Exploring the perceptions of obesity, health habits, stigma, and eating behaviors in BrazilLuiz F Viola, Fabiana Mandel, Cynthia M Valerio, et al.
Archives of Endocrinology and Metabolism|August 16, 2023
"Anti-obesity medications" or "medications to treat obesity" instead of "weight loss drugs" - why language matters - an official statement of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO) and the Brazilian Society of Endocrinology and Metabolism (SBEM)Bruno Halpern, Marcio C Mancini, Simone van de Sande-Lee, et al.
Lancet (London, England)|July 5, 2025
Reflections on the Lancet Commission on Investing in Health's Global Health 2050 reportJohanna Ralston, Simón Barquera, Louise Baur, et al.
International Journal of Obesity (2005)|September 27, 2025
Effects of tirzepatide on weight management in patients with and without diabetes: a systematic review and meta-analysisEduardo Cerchi, Paula Arruda do Espírito Santo, Mariana Carvalho de Oliveira, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Diabetologia|June 18, 2016
Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapyBruno Halpern, Cintia Cercato, Marcio C Mancini
Diabetes Care|May 24, 2017
Comment on Cummings and Cohen. Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m<sup>2</sup>. Diabetes Care 2016;39:924-933Bruno Halpern, Cintia Cercato, Marcio Correa Mancini
The Journal of Clinical Endocrinology and Metabolism|May 31, 2018
Case Report of Acquired Generalized Lipodystrophy Associated With Common Variable ImmunodeficiencyBruno Halpern, Marcia Nery, Maria Adelaide Albergaria Pereira
Diabetology & Metabolic Syndrome|March 5, 2022
Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerationsThiago Bosco Mendes, Alexandre Barbosa Câmara-de-Souza, Bruno Halpern
Obesity Research & Clinical Practice|June 18, 2020
Extrinsic compression of pancreatic duct by intragastric balloon treatment and its potential to cause acute pancreatitis: Two case reports and clinical discussionBruno Halpern, Mauricio Paulin Sorbello, Hilton Telles Libanori, et al.
Obesity Research & Clinical Practice|March 5, 2020
Extrinsic compression of pancreactic duct by intragastric balloon treatment and its potential to cause acute pancreatitis: two case reports and clinical discussionBruno Halpern, Mauricio Paulin Sorbello, Hilton Telles Libanori, et al.
Diabetology & Metabolic Syndrome|April 8, 2025
Exploring the perceptions of obesity, health habits, stigma, and eating behaviors in BrazilLuiz F Viola, Fabiana Mandel, Cynthia M Valerio, et al.
Archives of Endocrinology and Metabolism|August 16, 2023
"Anti-obesity medications" or "medications to treat obesity" instead of "weight loss drugs" - why language matters - an official statement of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO) and the Brazilian Society of Endocrinology and Metabolism (SBEM)Bruno Halpern, Marcio C Mancini, Simone van de Sande-Lee, et al.
Lancet (London, England)|July 5, 2025
Reflections on the Lancet Commission on Investing in Health's Global Health 2050 reportJohanna Ralston, Simón Barquera, Louise Baur, et al.
International Journal of Obesity (2005)|September 27, 2025
Effects of tirzepatide on weight management in patients with and without diabetes: a systematic review and meta-analysisEduardo Cerchi, Paula Arruda do Espírito Santo, Mariana Carvalho de Oliveira, et al.
Pageof 7